| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EJMECH.2004.01.007 |
| P698 | PubMed publication ID | 15072843 |
| P2093 | author name string | Matthias U Kassack | |
| Peter Nickel | |||
| Günter Lambrecht | |||
| Heiko Ullmann | |||
| Gregor Müller | |||
| Kirsten Braun | |||
| Matthias Ganso | |||
| Barbara Böing | |||
| P433 | issue | 4 | |
| P304 | page(s) | 345-357 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | European Journal of Medicinal Chemistry | Q3008624 |
| P1476 | title | Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist | |
| P478 | volume | 39 |
| Q35122793 | Activation and regulation of purinergic P2X receptor channels |
| Q35972396 | Bacillus bombysepticus α-Toxin Binding to G Protein-Coupled Receptor Kinase 2 Regulates cAMP/PKA Signaling Pathway to Induce Host Death |
| Q88643533 | Design, Synthesis, and Evaluation of Novel Immunomodulatory Small Molecules Targeting the CD40⁻CD154 Costimulatory Protein-Protein Interaction |
| Q40643618 | Development of a comprehensive set of P2 receptor pharmacological research compounds |
| Q36462318 | Identification of Rift Valley fever virus nucleocapsid protein-RNA binding inhibitors using a high-throughput screening assay |
| Q92648839 | Integration of purinergic and angiotensin II receptor function in renal vascular responses and renal injury in angiotensin II-dependent hypertension |
| Q93551700 | Ligand-Gated Ion Channels |
| Q33225547 | MRS2500 [2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice |
| Q39832611 | Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors |
| Q35873582 | Medicinal chemistry of adenosine, P2Y and P2X receptors |
| Q40725974 | Molecular basis of selective antagonism of the P2X1 receptor for ATP by NF449 and suramin: contribution of basic amino acids in the cysteine-rich loop |
| Q35580443 | Molecular recognition at adenine nucleotide (P2) receptors in platelets. |
| Q30982341 | NF449 is a novel inhibitor of fibroblast growth factor receptor 3 (FGFR3) signaling active in chondrocytes and multiple myeloma cells |
| Q38306634 | P2 receptors and platelet function |
| Q93498760 | P2X |
| Q37703255 | P2X purinergic receptor ligands: recently patented compounds |
| Q37468664 | P2X1 receptor-mediated inhibition of the proliferation of human coronary smooth muscle cells involving the transcription factor NR4A1 |
| Q91597385 | Profiling of a suramin-derived compound library at recombinant human P2Y receptors identifies NF272 as a competitive but non-selective P2Y2 receptor antagonist |
| Q38336214 | Selectivity of pharmacological tools: implications for use in cell physiology. A review in the theme: Cell signaling: proteins, pathways and mechanisms. |
| Q90575170 | Shiga toxin signals via ATP and its effect is blocked by purinergic receptor antagonism |
| Q47661976 | Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction |
| Q27682135 | Structural bases of norovirus RNA dependent RNA polymerase inhibition by novel suramin-related compounds |
| Q64118080 | Structure-Activity Relationship of NF023 Derivatives Binding to XIAP-BIR1 |
| Q58844844 | Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins) |
| Q64121534 | The ATP-gated P2X ion channel contributes to the severity of antibody-mediated Transfusion-Related Acute Lung Injury in mice |
| Q30486732 | The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels. |
| Q37702209 | The P2X1 ion channel in platelet function |
| Q38306728 | The P2X1 receptor and platelet function |
| Q28550039 | The Suramin Derivative NF449 Interacts with the 5-fold Vertex of the Enterovirus A71 Capsid to Prevent Virus Attachment to PSGL-1 and Heparan Sulfate |
| Q46699751 | The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range |
| Q24676296 | Use-dependent inhibition of the skeletal muscle ryanodine receptor by the suramin analogue NF676 |
Search more.